Arnav Biotech
Arnav Biotech is an mRNA manufacturing and contract research company focused on developing high-quality, custom mRNA for therapeutic, vaccine, diagnostic, and agricultural applications. The company aims to support academic and industry scientists in developing mRNA-based therapeutics and vaccines through expert design and optimization.
Arnav Biotech
380 Northyards Blvd. NW, Atlanta, GA 30313
What We Do
High quality and high purity mRNA for research use only, with options for capping, tailing, and modified bases.
Expert scientists help design mRNA candidates for research, ensuring high stability and translation.
Wide range of custom conjugation services to enable tracking of mRNA and other applications.
Unique pre-designed, fully capped and poly-adenylated mRNAs for applications such as screening delivery formulations in vitro and in vivo.
For tracking mRNA using fluorescence or luminescence based detection methods.
Detect biological activity of delivered mRNA using Cre or Beta-galactosidase.
Biologics
Drugs
Key People
Co-founder and CEO
Co-inventor and COO
News & Updates
ARNAV Biotech has announced an exclusive license agreement with Alabama State University for a novel anti-respiratory syncytial virus (RSV) therapeutics, aiming to move the drug quickly to pre-IND and IND enabling studies.
Collaboration to develop a purification and analytical platform for the Arnav Biotech mRNA pipeline, leveraging Sartorius BIA Separations’ platforms for purification and analytics.